Table 2.
Variable | NAFLD assessed by CNS (n=4,291, 29.6%) | NAFLD assessed by NLFS (n=4,158, 28.7%) | NAFLD assessed by HSI (n=3,153, 21.7%) | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
AOR | 95% CI | P value | AOR | 95% CI | P value | AOR | 95% CI | P value | |
Adjusted model 1a | |||||||||
LF/TF ratio Q1 | 7.86 | 6.01–10.26 | <0.001 | 6.29 | 5.11–7.73 | <0.001 | 3.37 | 2.56–4.44 | <0.001 |
LF/TF ratio Q2 | 4.08 | 3.15–5.30 | <0.001 | 3.25 | 2.65–3.98 | <0.001 | 2.66 | 2.03–3.49 | <0.001 |
LF/TF ratio Q3 | 2.36 | 1.81–3.07 | <0.001 | 1.95 | 1.59–2.40 | <0.001 | 1.64 | 1.25–2.16 | <0.001 |
LF/TF ratio Q4 | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |||
| |||||||||
Adjusted model 2b | |||||||||
LF/TF ratio Q1 | 7.96 | 5.97–10.61 | <0.001 | 6.26 | 4.99–7.85 | <0.001 | 3.29 | 2.45–4.42 | <0.001 |
LF/TF ratio Q2 | 3.94 | 2.98–5.19 | <0.001 | 3.05 | 2.45–3.81 | <0.001 | 2.61 | 1.96–3.47 | <0.001 |
LF/TF ratio Q3 | 2.36 | 1.78–3.12 | <0.001 | 1.89 | 1.51–2.36 | <0.001 | 1.67 | 1.26–2.23 | <0.001 |
LF/TF ratio Q4 | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | |||
| |||||||||
Adjusted model 3c | |||||||||
LF/TF ratio Q1 | 3.05 | 2.11–4.40 | <0.001 | 2.32 | 1.71–3.15 | <0.001 | 2.15 | 1.55–2.97 | <0.001 |
LF/TF ratio Q2 | 1.97 | 1.38–2.80 | <0.001 | 1.43 | 1.06–1.92 | 0.018 | 2.05 | 1.51–2.80 | <0.001 |
LF/TF ratio Q3 | 1.46 | 1.02–2.08 | 0.038 | 1.19 | 0.88–1.60 | 0.254 | 1.42 | 1.05–1.94 | 0.025 |
LF/TF ratio Q4 | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference |
AOR, adjusted odds ratio; CI, confidence interval; NAFLD, non-alcoholic fatty liver disease; CNS, comprehensive NAFLD score; NLFS, NAFLD liver fat score; HSI, hepatic steatosis index; LF/TF, leg fat to total fat.
Logistic models were adjusted for age, sex, and body mass index (BMI);
Logistic models were adjusted for age, sex, BMI, sarcopenia index, hypertension status, diabetes mellitus status, regular exercise, smoking, and drinking status;
Logistic models were adjusted for age, sex, BMI, sarcopenia index, hypertension status, diabetes mellitus status, regular exercise, smoking, drinking status, homeostasis model assessment of insulin resistance, high-density lipoprotein cholesterol levels, and triglyceride levels.